Christoph UHEREK

Person

Seligenstadt, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Uses of immunoconjugates targeting CD138
- Patent number 10,117,932
- Issue date Nov 6, 2018
- Biotest AG
- Gregor Schulz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents for treating disease
- Patent number 9,995,733
- Issue date Jun 12, 2018
- Biotest AG
- Frank Osterroth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized anti-IL-10 antibodies for the treatment of systemic lupus...
- Patent number 9,605,066
- Issue date Mar 28, 2017
- Biotest AG
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating psoriasis
- Patent number 9,550,831
- Issue date Jan 24, 2017
- Biotest AG
- Silke Aigner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of antibodies for detection of IL-10
- Patent number 9,540,436
- Issue date Jan 10, 2017
- Biotest AG
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agent for treating disease
- Patent number 9,512,226
- Issue date Dec 6, 2016
- Biotest AG
- Matthias Germer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and agents for improving targeting of CD138 expressing tumo...
- Patent number 9,446,146
- Issue date Sep 20, 2016
- Biotest AG
- Benjamin Daelken
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates targeting CD138 and uses thereof
- Patent number 9,387,261
- Issue date Jul 12, 2016
- Biotest AG
- Elmar Kraus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating psoriasis
- Patent number 9,334,325
- Issue date May 10, 2016
- Biotest AG
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of immunoconjugates targeting CD138
- Patent number 9,289,509
- Issue date Mar 22, 2016
- Biotest AG
- Frank Osterroth
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Agents targeting CD138 and uses thereof
- Patent number 9,221,914
- Issue date Dec 29, 2015
- Biotest AG
- Elmar Kraus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of decreasing cytotoxic side-effects and improving efficacy...
- Patent number 9,011,864
- Issue date Apr 21, 2015
- Biotest AG
- Gregor Schulz
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Humanized anti-IL 10 antibodies for the treatment of systemic lupus...
- Patent number 8,956,607
- Issue date Feb 17, 2015
- Biotest AG
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-IL-10 antibodies for the treatment of systemic lupus...
- Patent number 8,852,871
- Issue date Oct 7, 2014
- Biotest AG
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USES OF IMMUNOCONJUGATES TARGETING CD138
- Publication number 20190117770
- Publication date Apr 25, 2019
- Biotest AG
- Gregor Schulz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
- Publication number 20170081418
- Publication date Mar 23, 2017
- Biotest AG
- Elmar KRAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS TARGETING CD138 AND USES THEREOF
- Publication number 20160185854
- Publication date Jun 30, 2016
- Biotest AG
- Elmar Kraus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...
- Publication number 20150218270
- Publication date Aug 6, 2015
- Biotest AG
- Frank OSTERROTH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...
- Publication number 20150064179
- Publication date Mar 5, 2015
- Biotest AG
- Frank Osterroth
- G01 - MEASURING TESTING
Information Patent Application
USES OF IMMUNOCONJUGATES TARGETING CD138
- Publication number 20140010828
- Publication date Jan 9, 2014
- ImmunoGen, Inc.
- Gregor Schulz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS FOR TREATING DISEASE
- Publication number 20130004513
- Publication date Jan 3, 2013
- Frank Osterroth
- G01 - MEASURING TESTING
Information Patent Application
HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...
- Publication number 20120321617
- Publication date Dec 20, 2012
- Biotest AG
- Frank Osterroth
- G01 - MEASURING TESTING
Information Patent Application
HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...
- Publication number 20120321618
- Publication date Dec 20, 2012
- Biotest AG
- Frank Osterroth
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITION FOR TREATING DISEASE
- Publication number 20110229465
- Publication date Sep 22, 2011
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF IMMUNOCONJUGATES TARGETING CD138
- Publication number 20110123554
- Publication date May 26, 2011
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENT FOR TREATING DISEASE
- Publication number 20110059082
- Publication date Mar 10, 2011
- Matthias Germer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENT FOR TREATING DISEASE
- Publication number 20110059083
- Publication date Mar 10, 2011
- Silke Aigner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENT FOR TREATING DISEASE
- Publication number 20110059084
- Publication date Mar 10, 2011
- Frank Osterroth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
- Publication number 20090232810
- Publication date Sep 17, 2009
- Elmar Kraus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF DECREASING CYTOTOXIC SIDE-EFFECTS AND IMPROVING EFFICACY...
- Publication number 20090181038
- Publication date Jul 16, 2009
- Gregor Schulz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS TARGETING CD138 AND USES THEREOF
- Publication number 20090175863
- Publication date Jul 9, 2009
- Elmar Kraus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND AGENTS FOR IMPROVING TARGETING OF CD138 EXPRESSING TUMO...
- Publication number 20090169570
- Publication date Jul 2, 2009
- Benjamin Daelken
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christoph UHEREK

Person

Patents Grantslast 30 patents

Uses of immunoconjugates targeting CD138

Agents for treating disease

Humanized anti-IL-10 antibodies for the treatment of systemic lupus...

Method for treating psoriasis

Use of antibodies for detection of IL-10

Agent for treating disease

Methods and agents for improving targeting of CD138 expressing tumo...

Immunoconjugates targeting CD138 and uses thereof

Method for treating psoriasis

Uses of immunoconjugates targeting CD138

Agents targeting CD138 and uses thereof

Method of decreasing cytotoxic side-effects and improving efficacy...

Humanized anti-IL 10 antibodies for the treatment of systemic lupus...

Humanized anti-IL-10 antibodies for the treatment of systemic lupus...

Patents Applicationslast 30 patents

USES OF IMMUNOCONJUGATES TARGETING CD138

IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF

AGENTS TARGETING CD138 AND USES THEREOF

HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...

HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...

USES OF IMMUNOCONJUGATES TARGETING CD138

AGENTS FOR TREATING DISEASE

HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...

HUMANIZED ANTI-IL 10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS...

COMPOSITION FOR TREATING DISEASE

USES OF IMMUNOCONJUGATES TARGETING CD138

AGENT FOR TREATING DISEASE

AGENT FOR TREATING DISEASE

AGENT FOR TREATING DISEASE

IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF

METHOD OF DECREASING CYTOTOXIC SIDE-EFFECTS AND IMPROVING EFFICACY...

AGENTS TARGETING CD138 AND USES THEREOF

METHODS AND AGENTS FOR IMPROVING TARGETING OF CD138 EXPRESSING TUMO...